Health
Novo’s weight-loss drug Wegovy reduces risk of heart disease and strokes by 20%, shows study
Novo Nordisk A/S shares reached a new high after eagerly awaited research found that the Danish company’s blockbuster obesity medicine Wegovy lowered…